BALPHARMA — Bal Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Bal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	—	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,711	2,505	2,812	3,042	3,392
Cost of Revenue
Gross Profit	873	996	1,137	1,314	1,475
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	1,740	2,356	2,668	2,882	3,178
Operating Profit	-29.2	149	144	160	215
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-135	41	91.8	47.5	90.5
Provision for Income Taxes
Net Income After Taxes	-129	47.1	57	26.2	74.5
Minority Interest
Net Income Before Extraordinary Items
Net Income	-122	47.4	56.1	25.7	73.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-122	47.4	56.1	25.7	73.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-8.62	3.34	3.71	1.63	4.64
Dividends per Share